Presenter: Dr. Michael Allan James McCormack BSc (Pharm) Pharm D
In episode 480, James and Mike talk about two recent meta-analyses that have done a solid job of looking at the impact of lowering blood pressure and using SGLT-2s and GLP-1s to reduce risk. Both publications lend credence to the concept of focusing much more on risk reduction goals than blood pressure or glucose thresholds….
In the Clinic Episode #21: Low Back Pain
In the Clinic Episode #20: Bronchiolitis
In the Clinic Episode #19: Alcohol use disorder
![](https://cfpclearn.ca/wp-content/uploads/2022/09/CroppedIllustrations-24.png)
Presenter(s):
Dr. Michael Allan James McCormack BSc (Pharm) Pharm D
Please provide any additional comments (optional).